甲硫氨酰-tRNA合成酶1抗体染色在胆管癌刷检细胞学中的诊断价值
该研究评估了甲硫氨酰-tRNA合成酶1(MARS1)免疫荧光(IF)和免疫组化(IHC)染色在胆管刷检细胞学中的诊断价值。对80例肝外胆管狭窄患者的刷检标本进行MARS1 IF染色,并与常规巴氏染色比较;另对45例手术切除的胆管腺癌和正常胆管组织进行MARS1 IHC评估。结果显示MARS1 IF染色灵敏度、特异度、准确率分别为98.1%、96.1%、97.5%,显著优于巴氏染色(P < .0001),且MARS1在胆管腺癌中高表达。
要点
- MARS1 IF染色在胆管刷检细胞学中灵敏度98.1%、准确率97.5%,显著高于常规巴氏染色。
- MARS1在胆管腺癌组织中高表达,正常胆管组织不表达。
- MARS1 IF染色有望提高不明原因胆管狭窄的恶性检出率。
核心结论
- MARS1 IF染色具有高灵敏度和准确率,可在不明原因胆管狭窄患者中检测恶性病变。
研究设计与样本
- 对80例肝外胆管狭窄患者ERCP获得的胆管刷检细胞学标本进行巴氏和MARS1 IF染色。
- 对45例因恶性胆管狭窄手术患者的胆管腺癌和正常胆管组织切片进行MARS1 IHC染色。
主要发现
- MARS1 IF染色在恶性胆管结构中显示强信号,在恶性阴性标本中无信号。
- 常规巴氏染色灵敏度70.4%、特异度96.2%、阳性预测值97.4%、阴性预测值56.8%、准确率78.8%。
- MARS1 IF染色灵敏度98.1%、特异度96.1%、阳性预测值98.1%、阴性预测值96.2%、准确率97.5%(P < .0001)。
- IHC染色显示MARS1在45例胆管腺癌切片中检测到,在15例正常胆管切片中未检测到。
- PCR和Western blot显示胆管腺癌切片中MARS1 mRNA和蛋白水平显著升高。
关键数值与推荐
- MARS1 IF染色诊断恶性胆管狭窄的灵敏度98.1%、特异度96.1%、准确率97.5%。
- 常规巴氏染色诊断恶性胆管狭窄的灵敏度70.4%、特异度96.2%、准确率78.8%。
临床怎么用
- 对于不明原因胆管狭窄,可考虑采用MARS1 IF染色辅助刷检细胞学诊断。
局限性
- 需要进一步前瞻性研究验证本研究发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Identifying malignant biliary strictures using endobiliary brushing cytology specimens is important for treatment decision-making and prognosis prediction. The sensitivity of brushing cytology specimens based on Papanicolaou (Pap) staining is low, which hampers accurate diagnosis of indeterminate strictures. Here, we assessed the diagnostic value of immunohistochemical (IHC) and immunofluorescence (IF) staining for methionyl-tRNA synthetase 1 (MARS1). METHODS: Endobiliary brushing cytology specimens were obtained during ERCP from 80 patients with an extrahepatic biliary stricture. Pap and MARS1 IF staining were performed on liquid-based cytology slides derived from these specimens. Sections of bile duct adenocarcinoma and normal bile duct tissue were obtained from 45 patients who underwent surgery for malignant biliary stricture, and MARS1 levels were evaluated by IHC staining. RESULTS: MARS1 IF staining was applied to brushing cytology specimens, and the results showed strong signals in malignant biliary structures but not in the negative for malignancy specimens. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 70.4%, 96.2%, 97.4%, 56.8%, and 78.8%, respectively, for conventional Pap staining and 98.1%, 96.1%, 98.1%, 96.2%, and 97.5%, respectively, for MARS1 IF (P < .0001). When IHC staining was used, MARS1 was detected in 45 bile duct adenocarcinoma sections but not in 15 normal bile duct sections. Moreover, MARS1 mRNA and protein levels were significantly higher in bile duct adenocarcinoma sections according to polymerase chain reaction and Western blot, respectively. CONCLUSIONS: The high sensitivity and accuracy of MARS1 IF staining enabled detection of malignancy in patients with indeterminate biliary stricture. Further prospective studies are needed to validate our findings. (Clinical trial registration number: KCT 0003285.).
引用
- Jang SI, Kwon NH, Lim BJ, et al. New staining method using methionyl-tRNA synthetase 1 antibody for brushing cytology of bile duct cancer. Gastrointest Endosc. 2019. PMID: 31874158. doi:10.1016/j.gie.2019.12.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。